Pharma Times

SEPTEMBER 1, 2020

Rybelsus is the world’s first and only oral GLP-1 receptor agonist

Diabetes 146

Diabetes 146

pharmaphorum

SEPTEMBER 2, 2020

While the effects of COVID-19 have been devastating for many industries, its positive impact on accelerating the uptake of digital health technologies and virtual collaboration solutions is undeniable. This has been a long time coming and there are countless reasons why I believe virtual collaboration and medical education are here to stay, long after there is a vaccine for COVID-19 and physical distancing guidelines have been lifted. 1.

Communication 128

Communication Vaccines 128

NY Times

SEPTEMBER 2, 2020

A study of their therapy and clinical trials of other experimental treatments are offering glimmers of hope that paralysis from the disorder can be slowed.

105

105

Outsourcing Pharma

SEPTEMBER 3, 2020

Innovative research by Tabula Rasa Healthcare uses simulation technology to analyze potential adverse drug events of potential therapies for the virus.

98

98

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Pharma Times

SEPTEMBER 3, 2020

Scientists have discovered that hard-to-treat pancreatic cancer hijacks a key immune system response

Immunization 142

Immunization Immunity 142

Pharma Mirror

SEPTEMBER 4, 2020

The first digital session of Medical Device Innovation Summit concludes on a positive note with industry leaders addressing burning topics to promote innovation in the medical equipment industry. From challenges like lack of regulatory systems to its new found potential of manufacturing indigenous products on a large scale, the summit successfully addressed discussions on new.

80

80

Outsourcing Pharma

AUGUST 31, 2020

A recent study from healthcare insights company Sermo shares information and perspectives that trial and pharma professionals could learn from.

96

96

Pharma Times

SEPTEMBER 3, 2020

NICE has concerns with the evidence submitted but Janssen insists the nasal spray is a cost-effective use of NHS resources

130

130

pharmaphorum

SEPTEMBER 3, 2020

UK biotech Compass Pathways is planning a $100 million US IPO as it seeks to further develop its depression treatment based on psilocybin – an active ingredient that can be found in magic mushrooms. In a filing with the US financial regulator Compass laid out its plans to develop the drug known as COMP360, which is a crystalline formulation of psilocybin in phase 2b clinical development in patients who have not responded to standard therapy for depression.

Controlled Substances 116

Controlled Substances 116

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

Eye on FDA

SEPTEMBER 2, 2020

Since last week’s posting regarding FDA credibility being on the line, there has been a swirl of activity and commentary around the evaluation of vaccine research for COVID-19 that would seem to have exacerbated the problem. For context, last week the President issued a tweet stating that people were operating within FDA to slow progress on a vaccine without supplying any evidence, credible or otherwise, to support that.

Vaccines 65

Vaccines 65

Outsourcing Pharma

SEPTEMBER 1, 2020

A new scientific report offers a comprehensive review of protein targets, associated COVID-19 drug candidates to date and other revealing information.

79

79

Pharma Times

SEPTEMBER 2, 2020

The decision allows use of the therapy in the EU in children as young as six years of age

130

130

pharmaphorum

SEPTEMBER 3, 2020

NICE has rejected regular NHS funding for Janssen’s depression spray Spravato (esketamine) for a second time, although the company says it could salvage the situation by providing further data and “additional discussions”. This will likely see the company drop its price further after already offering a commercially confidential discount to the NHS following European approval late last year.

115

115

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

NY Times

SEPTEMBER 1, 2020

Meditation apps, tinctures, stress-busting gummies — spending on commercials for all of them is rising amid the pandemic’s climbing death toll and economic strain.

60

60

Outsourcing Pharma

SEPTEMBER 3, 2020

A company leader outlines the importance of increasing diversity in clinical trial patient populations, and how researchers can improve their results.

68

68

Pharma Times

SEPTEMBER 1, 2020

Clinical development of AZD1222 is progressing globally with late-stage clinical trials ongoing in the UK, Brazil and South Africa

Vaccines 130

Vaccines 130

pharmaphorum

SEPTEMBER 3, 2020

GlaxoSmithKline is opening a £10 million artificial intelligence (AI) research hub in King’s Cross, London, according to a press report. The area is being reimagined as a life sciences and technology hub and is already home to the Francis Crick Institute biomedical research organisation. King’s Cross is also home to Google’s DeepMind artificial intelligence company, which has already been involved in life sciences projects such as using the technology to predict acute kidney injury.

114

114

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

NY Times

SEPTEMBER 2, 2020

The idea behind convalescent plasma is attractively simple, but we just don’t know enough.

56

56

Outsourcing Pharma

SEPTEMBER 3, 2020

The companies will join forces to use IntelGenxâs polymeric film technologies for development of pharmaceutical-grade psychedelic drug treatments.

63

63

Pharma Times

SEPTEMBER 4, 2020

The findings have validated confidence in the experimental vaccine, the firm noted

Vaccines 129

Vaccines 129

pharmaphorum

SEPTEMBER 2, 2020

Cancer immunotherapy has set new standards in care, with some impressive responses in those patients lucky enough to respond. But many patients still do not respond to therapies such as Merck & Co’s anti PD-1 therapy Keytruda (pembrolizumab), or go on to develop progressive disease, and pharma companies are looking for new second-line therapies.

Immunity 111

Immunity Immunization 111

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

NY Times

SEPTEMBER 3, 2020

Pfizer’s chief executive, Dr. Albert Bourla, said the drug-making company is in a “very advanced stage” and should know by the end of October whether the coronavirus vaccine they are developing is safe and effective.

Vaccines 54

Vaccines 54

Outsourcing Pharma

AUGUST 31, 2020

The company intends to enable pharma and biotech companies to have greater access to cryo-electronic microscopy for their research projects.

59

59

Pharma Times

SEPTEMBER 2, 2020

The test can typically identify SARS-CoV-2 infection within 15 minutes

123

123

pharmaphorum

SEPTEMBER 1, 2020

Sanofi has drawn another blank in its attempt to repurpose its IL-6 drug Kevzara to tackle the extreme immune reaction seen in serious cases of COVID-19. The French pharma and development partner Regeneron have been testing Kevzara (sarilumab) in patients severely or critically ill and hospitalised with COVID-19. In severe cases of COVID-19, patients suffer a “cytokine storm” where the immune system becomes overstimulated and attacks the body.

Immunity 111

Immunity Immunization Hospitals 111

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.